The average Valeant Pharmaceuticals International Investor Relations in Boulder earns an estimated $59,992 annually. Valeant Pharmaceuticals International's Investor Relations compensation is $21,939 less than the US average for a Investor Relations.
In Boulder, The Communications Department at Valeant Pharmaceuticals International earns $9,775 more on average than the Enterprise Risk Department.
Last updated 2 years ago.
In Boulder, The Communications Department averages $9,775 more than the Enterprise Risk Department.
The average female Investor Relations at companies similar size to Valeant Pharmaceuticals International reported making $155,000, while the average male Investor Relations at similar sized companies reported making $50,000.
The majority of Investor Relations at Valeant Pharmaceuticals International believe they're compensated fairly. The vast majority (80%) of Investor Relations at Valeant Pharmaceuticals International are satisfied with their benefits. See more compensation ratings at Valeant Pharmaceuticals International